EMA Authorised: Imvanex (modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus) — Bavarian Nordic A/S

View source ↗

Summary

EMA authorised Imvanex (MVA-BN) from Bavarian Nordic A/S for protection against smallpox and monkeypox, expanding its indications to include monkeypox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox
• Smallpox

Drugs mentioned

• Imvanex (Modified vaccinia Ankara (MVA-BN) vaccine)

Snippet

Status: Authorised. Therapeutic area: Smallpox Vaccine;Monkeypox virus. MAH: Bavarian Nordic A/S. Decision date: 16/10/2025